Position in LLY
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$56,176,507
+$16,780,000 QoQ
Shares Held
46,836
+9.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#518
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$2,638,746
CallShares
2,200
PutValue
$1,079,487
PutShares
900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Concurrent Investment Advisors, LLC holds $273,585,885 across 14 Drug Manufacturers - General names. LLY ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
232,761 | $59,114,311 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
46,836 | $56,176,507 | |
| 3 | ABBV |
AbbVie Inc.
|
160,023 | $40,268,187 | |
| 4 | MRK |
Merck & Co., Inc.
|
280,871 | $36,091,923 | |
| 5 | PFE |
Pfizer Inc
|
891,770 | $21,473,821 | |
| 6 | AMGN |
Amgen Inc
|
51,650 | $18,703,497 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
266,252 | $15,341,440 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
81,664 | $10,317,429 |
All Filings in LLY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,176,507 | 46,836 | Shares | Sole | 2026-07-27 | |
| 2026-06-30 | $2,638,746 | 2,200 | Call | Sole | 2026-07-27 | |
| 2026-06-30 | $1,079,487 | 900 | Put | Sole | 2026-07-27 | |
| 2026-03-31 | $39,396,507 | 42,833 | Shares | Sole | 2026-04-21 | |
| 2026-03-31 | $919,770 | 1,000 | Put | Sole | 2026-04-21 | |
| 2025-12-31 | $214,936 | 200 | Call | Sole | 2026-01-29 | |
| 2025-12-31 | $2,149,360 | 2,000 | Put | Sole | 2026-01-29 | |
| 2025-12-31 | $43,433,195 | 40,415 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $22,090,376 | 28,952 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $22,910,386 | 29,390 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $22,857,059 | 27,675 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $77,200 | 100 | Call | Sole | 2025-02-03 | |
| 2024-12-31 | $18,852,240 | 24,420 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $88,594 | 100 | Call | Sole | 2024-10-30 | |
| 2024-09-30 | $21,093,345 | 23,809 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $20,926,953 | 23,114 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $11,881,005 | 15,272 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $8,649,949 | 14,839 | Shares | Sole | 2024-04-15 | |
| No filing history on record for this holder in this stock. | ||||||